Focus on
This webinar is produced in the framework of the EAPC Diabetes & CVD Educational Programme. Experts from the European Association of Preventive Cardiology (EAPC), European Association for the Study of Diabetes (EASD) Study Group on Diabetes & CVD, ESC Council for Cardiology Practice (CCP), Association of Cardiovascular Nursing and Allied Professions (ACNAP), ESC Working Group on Aorta and Peripheral Vascular Disease, ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Working Group on Thrombosis are involved in all stages of the programme development.
Learning Objectives
After watching this webinar, participants will be able to:
- Provide an overview of present screening for hyperglycaemia and management of patients with type 2 diabetes and atherosclerotic vascular disease;
- Understand the importance of multifactorial risk factor management; and
- Review available evidence behind novel glucose-lowering drugs with cardioprotective capacity and when to choose different types of such treatment.
Assoc. Prof. Linda Mellbin, FESC
Prof. Francesco Cosentino, FESC
Prof. Lars Ryden, FESC
Our mission: To reduce the burden of cardiovascular disease.